Variations in dynamic tumor-associated antigen-specific T cell responses correlate with HCC recurrence after thermal ablation

Variations in dynamic tumor-associated antigen-specific T cell responses correlate with HCC recurrence after thermal ablation

BackgroundAblative therapy is a recommended treatment for hepatocellular carcinoma (HCC) not only for its effective eradication of tumors, but also for its induction of host immunity. However, the high 5-year recurrence rate after ablation underlines the poor understanding of the antitumor immunity...

Full description

Bibliographic Details
Main Authors: Chaoran Zang, Yan Zhao, Guihai Liu, Kang Li, Ling Qin, Yuewei Zhang, Jianping Sun, Qi Wang, Liang Ma, Peng Zhao, Yu Sun, Dandan Guo, Chunwang Yuan, Tao Dong, Yonghong Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Immunology
Subjects:
hepatocellular carcinoma
ablation
tumor-associated antigen
T-cell immune response
recurrence
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.982578/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.982578/full

Similar Items